From Oprah to South Park, everyone is talking about GLP-1s and their potential to revolutionize obesity care, for better or worse. This panel will challenge you to move beyond social media chatter and market speculation and consider what really needs to change so industry leaders can work with consumers, clinicians, and change agents alike to unlock a more productive healthcare system and a healthier, sustainable future for all.